Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Butanedioic Acid, Iron (+2) Salt
2. Ferromyn
3. Ferrosuccinate
1. Iron Succinate
2. 10030-90-7
3. Iron(ii) Succinate
4. Butanedioate;iron(2+)
5. Butanedioic Acid, Iron(2+) Salt (1:1)
6. 818zyk7n91
7. Succinic Acid Iron(ii) Salt;succinic Acid Iron(ii) Salt
8. Unii-818zyk7n91
9. Ferrlecit 2
10. Einecs 233-082-3
11. Ferplex (tn)
12. Ferromyn
13. Succinic Acid Iron(ii) Salt
14. Schembl275423
15. Ferrous Succinate [mi]
16. Iron Succinate (fe(o4c4h4))
17. Ferrous Succinate [mart.]
18. Ferrous Succinate [who-dd]
19. Db14489
20. D08015
21. Succinic Acid, Iron(2+) Salt (1:1)
22. Q27269230
| Molecular Weight | 171.92 g/mol |
|---|---|
| Molecular Formula | C4H4FeO4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 171.945894 g/mol |
| Monoisotopic Mass | 171.945894 g/mol |
| Topological Polar Surface Area | 80.3 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 81.6 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Used in preventing and treating iron-deficiency anemia.
The major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. Iron has putative immune-enhancing, anticarcinogenic and cognition-enhancing activities.
Hematinics
Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)
B - Blood and blood forming organs
B03 - Antianemic preparations
B03A - Iron preparations
B03AA - Iron bivalent, oral preparations
B03AA06 - Ferrous succinate
Absorption
The efficiency of absorption depends on the salt form, the amount administered, the dosing regimen and the size of iron stores. Subjects with normal iron stores absorb 10% to 35% of an iron dose. Those who are iron deficient may absorb up to 95% of an iron dose.
Iron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Ferrous Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ferrous Succinate, including repackagers and relabelers. The FDA regulates Ferrous Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ferrous Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ferrous Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ferrous Succinate supplier is an individual or a company that provides Ferrous Succinate active pharmaceutical ingredient (API) or Ferrous Succinate finished formulations upon request. The Ferrous Succinate suppliers may include Ferrous Succinate API manufacturers, exporters, distributors and traders.
click here to find a list of Ferrous Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ferrous Succinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ferrous Succinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ferrous Succinate GMP manufacturer or Ferrous Succinate GMP API supplier for your needs.
A Ferrous Succinate CoA (Certificate of Analysis) is a formal document that attests to Ferrous Succinate's compliance with Ferrous Succinate specifications and serves as a tool for batch-level quality control.
Ferrous Succinate CoA mostly includes findings from lab analyses of a specific batch. For each Ferrous Succinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ferrous Succinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ferrous Succinate EP), Ferrous Succinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ferrous Succinate USP).
LOOKING FOR A SUPPLIER?
